COVID-19 Pandemic and Posttreatment Breast Cancer Surveillance and Outcomes

By afschroeder • July 18, 2025

Hahn EE, Eng S, Chen A, Haupt EC, Goodall S, Munoz-Plaza CE, Nguyen HQ, Gould MK, Ganz PA, Shen E. COVID-19 Pandemic and Posttreatment Breast Cancer Surveillance and Outcomes. JAMA Oncol. 2025 Jul 17. doi: 10.1001/jamaoncol.2025.1991. Epub ahead of print. PMID: 40674101.

Tags: Hematology/Oncology, Publications

Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti-PD-1-refractory Hodgkin lymphoma

Armand P, Zinzani PL, Timmerman JM, Johnson NA, Lavie D, Thiagarajan K, Topp B, Pillai PM, Herrera AF. Estimating efficacy of favezelimab plus pembrolizumab relative[...]

Complex Tricuspid and Pulmonic Carcinoid Heart Disease With Timely Surgical Repair

Hollowed J, Woo H, Hamburg S, Ardehali A. Complex Tricuspid and Pulmonic Carcinoid Heart Disease With Timely Surgical Repair. Tex Heart Inst J. 2025 Jul[...]

Incomplete Cancer Surgery Correlates With Loss of Immune Surveillance and Hyper-Progression of Disease

Fine SA, Lim SY, Siena NM, de Jesus AB, Goh T, Markus L, Russell TA, Kendal JK, Lofftus SY, Shehata MS, Dao HB, Lee A,[...]